Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

RETIN-A

TRETINOIN

Standard Dose
0.05%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview RETIN-A is listed in Drugs@FDA under application 016921 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TRETINOIN Form and strength SWAB;TOPICAL - 0.05% Sponsor VALEANT INTL Submission history Latest submission status date: 2002-06-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview RETIN-A is listed in Drugs@FDA under application 016921 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TRETINOIN Form and strength SWAB;TOPICAL - 0.05% Sponsor VALEANT INTL Submission history Latest submission status date: 2002-06-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.